This pre-clinical study hypothesizes that chronic administration of BHB (beta-hydroxybutyrate) replicates the therapeutic effects of ketogenic diet for schizophrenia in mice.
New Results: First RCT for Schizophrenia & Bipolar Disorder. Learn more.
This pre-clinical study hypothesizes that chronic administration of BHB (beta-hydroxybutyrate) replicates the therapeutic effects of ketogenic diet for schizophrenia in mice.
Fecal transplants from ketogenic diet-fed mice into a validated schizophrenia mouse model improved behavioral deficits. This suggests gut microbiome changes may help drive the ketogenic diet’s beneficial effects.
Read more
This pre-clinical study found that combining a ketogenic diet with regular voluntary exercise significantly reduced anxiety and depression-like behaviors in an animal model.
Read more
This pre-clinical study found that fasting or a short-term ketogenic diet can prevent rapid increases in blood glucose typically seen with antipsychotic medications.
Read more